Recent survey finds support for keeping parts of it intact, even those who want it repealed.
Read More »Monthly Archives: January 2017
ADA’s New Focus on Total Patient
What does it mean when we say we need to focus on the total or whole patient?
Read More »The Most Common Hassle For Type 1 Diabetes Patients
Barrier means more work including monitoring more often and making more adjustments.
Read More »The Future of Cardiovascular Research
Trial shows mobile devices may be useful in future health studies.
Read More »Video: Dr. Pam R. Taub, A Cardiologist’s Experience with Diabetes Patients
Dr. Pam Taub talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting about her experience as a cardiologist working with diabetes patients who are often coming to her for cardiology treatment and starting diabetes treatment as well.
Read More »Dr. Pam R. Taub Transcript
In the transcript of this exclusive interview, Dr. Taub discusses her experience as a cardiologist, seeing patients with various cardiac diseases, about 75% of whom have diabetes.
Read More »SGLT-2 or No?
Now that we have a drug (SGLT-2) that can prevent the death of those with diabetes by 38%, do you see yourself informing your patients about this option or will you stay with the status quo? 1) inform patients 2) Stay the course Follow the link to share your opinion!
Read More »Question 868
According to the Standards of Medical Care in Diabetes, which medication class places asymptomatic patients at increased risk of developing type 2 diabetes and is an additional indication for diabetes screening? A. Atypical antipsychotics B. Glucocorticoids C. Both A and B D. Neither A nor B Did you get it right? Follow the link to find out!
Read More »Dr. Pam R. Taub Part 1, A Cardiologist’s Perspective on Diabetes
Dr. Pam R. Taub talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 1 of this Exclusive Video, Dr. Taub explains her work with diabetes patients, who are a large percent of her practice and often start diabetes treatment with her before seeing a …
Read More »Dr. Pam R. Taub Part 2, New Cholesterol Drugs PCSK9 Inhibitors
Dr. Pam R. Taub talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 2 of this Exclusive Interview, Dr. Taub explains the use and effects of the latest cholesterol drugs, PCSK9-inhibitors. Dr. Pam R. Taub, MD, FACC is a board-certified cardiologist who focuses on general …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.